Ellume announces global partnership with QIAGEN for COVID-19 diagnosis
Highlights Ellume builds on existing partnership with global diagnostics company QIAGEN, to bring a rapid, reliable COVID antibody test to market QIAreach™ Anti-SARS-CoV-2 Total serology test has been submitted for US FDA Emergency Use Authorization 900,000 tests pre-ordered Brisbane, Australia – 25 August 2020 Digital diagnostics firm Ellume Ltd (Ellume or “the Company”) has extended […]
Read More

